The Importance of the Proof-of-Concept Stage while Producing a Glioblastoma Multiform Drug Candidate Video
Learn how TargTex partners with Nanoform to produce therapies for Glioblastoma patients. This process includes identifying novel targets with small molecules, utilizing Nanoform technology to increase the active pharmaceutical ingredient [API] concentration, and improving treatment stability to move the drug to clinical development.
Related Content
